NEWS
NEWS
Coronavirus tracker: T cells could provide hint to how Roche’s Actemra treats COVID-19 patients
A new study out of China has tied T cell activation to Roche's IL-6 inhibitor Actemra, which has shown some early effect in treating cytokine...
Blue Cross MN CEO: Why COVID-19 may be making the case for value-based care
COVID-19 is making the case for accelerating the move to more value-based models of care. Hospitals’ financial struggles as they pause...
Global clinical trials take a major hit from pandemic, with endocrine targeted tests worst hit
Clinical trial enrollment has dropped massively across the world with endocrine and cardiovascular tests being the hardest hit. This is according...
To avoid DTC dips and communication snafus, pharma marketing shifts amid COVID-19 crisis
Pharma marketing, like the rest of the ad industry, is in a state of flux brought on by the COVID-19 pandemic. Concerns and debates are swirling...
Trump tries to lure CureVac to make a ‘U.S. vaccine,’ but German government steps in
It’s a pretty extraordinary story that started off with a CEO exiting a biotech and has now become about the U.S. president allegedly wanting to...
LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst
NEWS
Coronavirus tracker: T cells could provide hint to how Roche’s Actemra treats COVID-19 patients
A new study out of China has tied T cell activation to Roche's IL-6 inhibitor Actemra, which has shown some early effect in treating cytokine...
Blue Cross MN CEO: Why COVID-19 may be making the case for value-based care
COVID-19 is making the case for accelerating the move to more value-based models of care. Hospitals’ financial struggles as they pause...
Global clinical trials take a major hit from pandemic, with endocrine targeted tests worst hit
Clinical trial enrollment has dropped massively across the world with endocrine and cardiovascular tests being the hardest hit. This is according...
To avoid DTC dips and communication snafus, pharma marketing shifts amid COVID-19 crisis
Pharma marketing, like the rest of the ad industry, is in a state of flux brought on by the COVID-19 pandemic. Concerns and debates are swirling...
Trump tries to lure CureVac to make a ‘U.S. vaccine,’ but German government steps in
It’s a pretty extraordinary story that started off with a CEO exiting a biotech and has now become about the U.S. president allegedly wanting to...
LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst